Ring Therapeutics believes that the next great viral vector is a ubiquitous, but little known, family of viruses already found in the body

Ring CEO Tuyen Ong introduces us to anelloviruses and describes the qualities that could make them compelling delivery vehicles. Animal data presented in an oral presentation at #ASGCT2024 today suggests that they can be re-dosed.